InvestorsHub Logo
Followers 53
Posts 4314
Boards Moderated 0
Alias Born 02/28/2010

Re: Turtle_0 post# 2840

Friday, 03/28/2014 5:11:28 PM

Friday, March 28, 2014 5:11:28 PM

Post# of 32016
The problem is that even if Afrezza is approved that Mannkind's market cap is still excessive if REMS are placed on Afrezza and a cancer warning is placed on the label as it was with Exubera.

Arena, Amarin, and Vivus all lost a substantial portion of their market cap after their "blockbuster" drugs were approved.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNKD News